More recently, Bryleva et al. (2010) by using a combined mouse genetic and biochemical approach, showed that ablation of ACAT1 gene in triple transgenic (3XTg-AD) mice leaded to more than 60% reduction in full-length human APP and its proteolytic fragments, and to an improvement in cognitive deficit. Here, ACAT1 is linked to Alzheimer disease.